Comerț Eli Lilly & Co - LLY CFD
Adăugare la favorite- Rezumat
- Istoric date
- Evenimente
- Declarația de venituri
- Bilanț
- Flux de numerar
- Proprietate
Spread | 2.49 | ||||||||
Taxă de la o zi la alta poziție lungă
Long position overnight fee
Accesați platforma | -0.030779% | ||||||||
Taxă de la o zi la alta poziție scurtă
Short position overnight fee
Accesați platforma | -0.013666% | ||||||||
Durată taxă de la o zi la alta | 22:00 (UTC) | ||||||||
Cantitate minimă tranzacționată | 1 | ||||||||
Monedă | USD | ||||||||
Marjă | 20% | ||||||||
Bursă | United States of America | ||||||||
Comision tranzacționare | 0% |
*Information provided by Capital.com
Eli Lilly and Co ESG Risk Ratings
‘B’ score indicates good relative ESG performance and above average degree of transparency in reporting material ESG data publicly.
Închis anterior* | 330.39 |
Deschis* | 329.73 |
Schimbare la 1 an* | 31.38% |
Interval zi* | 329.73 - 341.12 |
Interval 52 săpt. | 231.87-384.44 |
Volum mediu (10 zile) | 3.96M |
Volum mediu (3 luni) | 58.70M |
Capitalizare de piață | 314.22B |
Raport P/E | 47.91 |
Acțiuni în circulație | 950.18M |
Venit | 28.54B |
EPS | 6.90 |
Dividend (Randament%) | 1.3668 |
Beta | 0.33 |
Următoarea dată a câștigurilor | Apr 27, 2023 |
Toate datele sunt furnizate de Refinitiv, cu excepția datelor marcate cu un asterisc, care sunt *date furnizate de Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Zilnic
- Săptămânal
- Lunar
Date | Închidere | Change | Change (%) | Deschidere | Ridicat | Redus |
---|---|---|---|---|---|---|
Feb 2, 2023 | 330.39 | -2.41 | -0.72% | 332.80 | 334.80 | 316.14 |
Feb 1, 2023 | 342.15 | 1.23 | 0.36% | 340.92 | 345.40 | 336.80 |
Jan 31, 2023 | 343.91 | 5.17 | 1.53% | 338.74 | 344.11 | 338.74 |
Jan 30, 2023 | 340.18 | -1.86 | -0.54% | 342.04 | 347.28 | 339.15 |
Jan 27, 2023 | 341.77 | -2.99 | -0.87% | 344.76 | 347.70 | 341.32 |
Jan 26, 2023 | 347.65 | -2.14 | -0.61% | 349.79 | 351.79 | 346.30 |
Jan 25, 2023 | 349.26 | 7.35 | 2.15% | 341.91 | 349.50 | 341.91 |
Jan 24, 2023 | 345.92 | -16.82 | -4.64% | 362.74 | 364.89 | 339.80 |
Jan 23, 2023 | 341.82 | -2.04 | -0.59% | 343.86 | 345.86 | 339.80 |
Jan 20, 2023 | 345.80 | 1.01 | 0.29% | 344.79 | 348.73 | 341.12 |
Jan 19, 2023 | 350.82 | 1.39 | 0.40% | 349.43 | 355.30 | 349.43 |
Jan 18, 2023 | 351.45 | -4.05 | -1.14% | 355.50 | 358.73 | 351.25 |
Jan 17, 2023 | 357.38 | -1.09 | -0.30% | 358.47 | 361.50 | 356.17 |
Jan 13, 2023 | 361.23 | 6.08 | 1.71% | 355.15 | 362.95 | 355.15 |
Jan 12, 2023 | 358.72 | 3.25 | 0.91% | 355.47 | 360.15 | 351.69 |
Jan 11, 2023 | 359.86 | 7.67 | 2.18% | 352.19 | 361.49 | 348.71 |
Jan 10, 2023 | 352.54 | 5.75 | 1.66% | 346.79 | 352.96 | 342.22 |
Jan 9, 2023 | 349.45 | -13.34 | -3.68% | 362.79 | 364.60 | 348.43 |
Jan 6, 2023 | 362.71 | 4.92 | 1.38% | 357.79 | 366.20 | 356.41 |
Jan 5, 2023 | 358.63 | 0.04 | 0.01% | 358.59 | 360.94 | 350.85 |
Eli Lilly & Co Events
Time (UTC) | Country | Event |
---|---|---|
No events scheduled |
- Anual
- Trimestrial
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
---|---|---|---|---|---|---|
Venit total | 21222.1 | 19973.8 | 21493.3 | 22319.5 | 24539.8 | 28318.4 |
Venit | 21222.1 | 19973.8 | 21493.3 | 22319.5 | 24539.8 | 28318.4 |
Cost pentru venit, total | 5654.9 | 4447.7 | 4681.7 | 4721.2 | 5483.3 | 7312.8 |
Profit brut | 15567.2 | 15526.1 | 16811.6 | 17598.3 | 19056.5 | 21005.6 |
Cheltuieli operaționale totale | 17763.3 | 17970.5 | 17958.8 | 17287.9 | 18481.8 | 22366.5 |
Cheltuieli de vânzare/generale/Admin, total | 6452 | 5982.4 | 5975.1 | 6213.8 | 6121.2 | 6431.6 |
Cercetare dezvoltare | 5243.9 | 5096.2 | 5051.2 | 5595 | 6085.7 | 7025.9 |
Cheltuieli neobișnuite (venit) | 412.5 | 2444.2 | 2250.8 | 757.9 | 791.6 | 1596.2 |
Venit operațional | 3458.8 | 2003.3 | 3534.5 | 5031.6 | 6058 | 5951.9 |
Venit din dobânzi (cheltuială), net, neoperațional | -76.5 | -58.6 | -83.2 | -320.2 | -326.6 | -137.5 |
Altele, net | -8.3 | 360.1 | 228.8 | 554.5 | 1498.5 | 341.1 |
Venit net înainte de taxe | 3374 | 2304.8 | 3680.1 | 5265.9 | 7229.9 | 6155.5 |
Venit net după taxe | 2737.6 | 4493.6 | 3325.9 | 4637.9 | 6193.7 | 5581.7 |
Venit net înainte de alte elemente | 2737.6 | 4493.6 | 3325.9 | 4637.9 | 6193.7 | 5581.7 |
Venit net | 2737.6 | -204.1 | 3232 | 8318.4 | 6193.7 | 5581.7 |
Venit disponibil pentru elem. comune obișnuite excluse | 2737.6 | 4493.6 | 3325.9 | 4637.9 | 6193.7 | 5581.7 |
Venit disponibil pentru elem. comune obișnuite excluse | 2737.6 | -204.1 | 3232 | 8318.4 | 6193.7 | 5581.7 |
Venit net diluat | 2737.6 | -204.1 | 3232 | 8318.4 | 6193.7 | 5581.7 |
Acțiuni medii ponderate diluate | 1061.82 | 1052.02 | 1033.67 | 935.684 | 912.505 | 911.681 |
EPS diluat, exclusiv elem. extraordinare | 2.5782 | 4.27139 | 3.21757 | 4.95669 | 6.78758 | 6.12243 |
Dividends per Share - Common Stock Primary Issue | 2.04 | 2.08 | 2.25 | 2.58 | 2.96 | 3.4 |
EPS normalizat diluat | 2.89874 | 6.15171 | 5.37021 | 5.70063 | 7.63447 | 7.79951 |
Total elem. extraordinare | -4697.7 | -93.9 | 3680.5 | 0 | 0 |
Q1 2021 | Q2 2021 | Q3 2021 | Q4 2021 | Q1 2022 | |
---|---|---|---|---|---|
Venit total | 6805.6 | 6740.1 | 6772.8 | 7999.9 | 7810 |
Venit | 6805.6 | 6740.1 | 6772.8 | 7999.9 | 7810 |
Cost pentru venit, total | 1878.6 | 1953.2 | 1430.8 | 2050.2 | 2072.1 |
Profit brut | 4927 | 4786.9 | 5342 | 5949.7 | 5737.9 |
Cheltuieli operaționale totale | 5650.3 | 5336.7 | 5296.8 | 6082.7 | 5405.7 |
Cheltuieli de vânzare/generale/Admin, total | 1576 | 1685.7 | 1577.9 | 1592 | 1557.9 |
Cercetare dezvoltare | 1684.8 | 1672.8 | 1708.9 | 1959.4 | 1610.1 |
Cheltuieli neobișnuite (venit) | 510.9 | 25 | 579.2 | 481.1 | 165.6 |
Venit operațional | 1155.3 | 1403.4 | 1476 | 1917.2 | 2404.3 |
Venit din dobânzi (cheltuială), net, neoperațional | 219.2 | 133.9 | -323.4 | -167.2 | -503.3 |
Altele, net | 101.9 | 56.6 | 92.7 | 89.9 | 152.6 |
Venit net înainte de taxe | 1476.4 | 1593.9 | 1245.3 | 1839.9 | 2053.6 |
Venit net după taxe | 1355.3 | 1390.2 | 1110.1 | 1726.1 | 1902.9 |
Venit net înainte de alte elemente | 1355.3 | 1390.2 | 1110.1 | 1726.1 | 1902.9 |
Venit net | 1355.3 | 1390.2 | 1110.1 | 1726.1 | 1902.9 |
Venit disponibil pentru elem. comune obișnuite excluse | 1355.3 | 1390.2 | 1110.1 | 1726.1 | 1902.9 |
Venit disponibil pentru elem. comune obișnuite excluse | 1355.3 | 1390.2 | 1110.1 | 1726.1 | 1902.9 |
Venit net diluat | 1355.3 | 1390.2 | 1110.1 | 1726.1 | 1902.9 |
Acțiuni medii ponderate diluate | 912.4 | 910.4 | 910.8 | 911.624 | 906.4 |
EPS diluat, exclusiv elem. extraordinare | 1.48542 | 1.52702 | 1.21882 | 1.89343 | 2.0994 |
Dividends per Share - Common Stock Primary Issue | 0.85 | 0.85 | 0.85 | 0.85 | 0.98 |
EPS normalizat diluat | 2.02635 | 1.55448 | 1.80644 | 2.41408 | 2.28211 |
Total elem. extraordinare | 0 |
- Anual
- Trimestrial
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
---|---|---|---|---|---|---|
Total active prezente | 15101.4 | 19202.1 | 20549.6 | 13709.6 | 17462.1 | 18452.4 |
Numerar și investiții pe termen scurt | 6038.6 | 8034.1 | 7408.9 | 2438.5 | 3681.3 | 3908.6 |
Numerar & echivalent | 4582.1 | 6536.2 | 7320.7 | 2337.5 | 3657.1 | 3818.5 |
Investiții pe termen scurt | 1456.5 | 1497.9 | 88.2 | 101 | 24.2 | 90.1 |
Total creanțe, net | 4766.3 | 5262.2 | 5776.8 | 5541.5 | 6929 | 8127.2 |
Accounts Receivable - Trade, Net | 4029.4 | 4546.3 | 5776.8 | 4547.3 | 5875.3 | 6672.8 |
Total Inventory | 3561.9 | 4458.3 | 3098.1 | 3190.7 | 3980.3 | 3886 |
Prepaid Expenses | 734.6 | 1447.5 | 2036.7 | 2538.9 | 2871.5 | 2530.6 |
Total Assets | 38805.9 | 44981 | 43908.4 | 39286.1 | 46633.1 | 48806 |
Property/Plant/Equipment, Total - Net | 8252.6 | 8826.5 | 7996.1 | 8405 | 8681.9 | 8985.1 |
Property/Plant/Equipment, Total - Gross | 16777.6 | 18091.1 | 16663 | 17566.6 | 18252.6 | 18961.8 |
Accumulated Depreciation, Total | -8525 | -9264.6 | -8666.9 | -9161.6 | -9570.7 | -9976.7 |
Goodwill, Net | 3972.7 | 4370.1 | 1366.6 | 3679.4 | 3766.5 | 3892 |
Intangibles, Net | 4357.9 | 4029.2 | 1068 | 6618 | 7450 | 7691.9 |
Long Term Investments | 5207.5 | 5678.8 | 2005.4 | 1962.4 | 2966.8 | 3212.6 |
Other Long Term Assets, Total | 1913.8 | 2874.3 | 10922.7 | 4911.7 | 6305.8 | 6572 |
Total Current Liabilities | 10986.6 | 14535.9 | 11888.1 | 11775.2 | 12481.6 | 15052.7 |
Accounts Payable | 1349.3 | 1410.7 | 1207.1 | 1405.3 | 1606.7 | 1670.6 |
Accrued Expenses | 896.9 | 997.9 | 955.6 | 915.5 | 997.2 | 958.1 |
Notes Payable/Short Term Debt | 1299.3 | 2696.8 | 498.9 | 1494.2 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 638.1 | 1009.8 | 603.3 | 5.1 | 8.7 | 1538.3 |
Other Current Liabilities, Total | 6803 | 8420.7 | 8623.2 | 7955.1 | 9869 | 10885.7 |
Total Liabilities | 24798.2 | 33388.8 | 34079.7 | 36679.2 | 40991.5 | 39826.8 |
Total Long Term Debt | 8367.8 | 9940.5 | 9196.4 | 13817.9 | 16586.6 | 15346.4 |
Long Term Debt | 8358.8 | 9931.8 | 9196.4 | 13817.9 | 16586.6 | 15346.4 |
Capital Lease Obligations | 9 | 8.7 | ||||
Minority Interest | 72.8 | 75.7 | 1080.4 | 92.2 | 183.6 | 175.6 |
Other Liabilities, Total | 5371 | 8836.7 | 10602.1 | 8806.4 | 9639.8 | 7518.4 |
Total Equity | 14007.7 | 11592.2 | 9828.7 | 2606.9 | 5641.6 | 8979.2 |
Common Stock | 688.5 | 687.9 | 661 | 598.8 | 598.2 | 596.3 |
Additional Paid-In Capital | 5640.6 | 5817.8 | 6583.6 | 6685.3 | 6778.5 | 6833.4 |
Retained Earnings (Accumulated Deficit) | 16046.3 | 13894.1 | 11395.9 | 4920.4 | 7830.2 | 8958.5 |
Treasury Stock - Common | -80.5 | -75.8 | -69.4 | -60.8 | -55.7 | -52.7 |
Unrealized Gain (Loss) | 224 | 113.5 | 4.9 | 14.8 | 3.7 | |
Other Equity, Total | -8511.2 | -8845.3 | -8742.4 | -9541.7 | -9524.4 | -7360 |
Total Liabilities & Shareholders’ Equity | 38805.9 | 44981 | 43908.4 | 39286.1 | 46633.1 | 48806 |
Total Common Shares Outstanding | 1100.88 | 1100.01 | 1057.64 | 957.526 | 956.59 | 953.653 |
Other Current Assets, Total | 2229.1 | 0 | ||||
Deferred Income Tax | 1312.7 | 2187.5 | 2099.9 | 1733.7 |
Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | |
---|---|---|---|---|---|
Total active prezente | 16604.5 | 17295.5 | 17808.3 | 18452.4 | 16964.7 |
Numerar și investiții pe termen scurt | 3051.4 | 3271.2 | 3825.3 | 3908.6 | 2568.3 |
Numerar & echivalent | 3002.4 | 3220 | 3788.2 | 3818.5 | 2459.2 |
Investiții pe termen scurt | 49 | 51.2 | 37.1 | 90.1 | 109.1 |
Total creanțe, net | 6658.6 | 6902.8 | 7025 | 8127.2 | 7805.7 |
Accounts Receivable - Trade, Net | 5592.8 | 5829.4 | 5914.3 | 6672.8 | 6322.5 |
Total Inventory | 3660.8 | 3824.9 | 3907.4 | 3886 | 3893 |
Prepaid Expenses | 3233.7 | 3296.6 | 3050.6 | 2530.6 | 2697.7 |
Total Assets | 46838.3 | 47809 | 48187 | 48806 | 46919.3 |
Property/Plant/Equipment, Total - Net | 8630.1 | 8855.5 | 8920.4 | 8985.1 | 9102.7 |
Property/Plant/Equipment, Total - Gross | 18273.5 | 18697.7 | 18883.2 | 18961.8 | 19241 |
Accumulated Depreciation, Total | -9643.4 | -9842.2 | -9962.8 | -9976.7 | -10138.3 |
Goodwill, Net | 3877.4 | 3884.2 | 3884.1 | 3892 | 3892 |
Intangibles, Net | 8087.8 | 7985.4 | 7887.7 | 7691.9 | 7482.4 |
Long Term Investments | 3232.4 | 3474.9 | 3350.5 | 3212.6 | 2727.3 |
Other Long Term Assets, Total | 6406.1 | 6313.5 | 6336 | 6572 | 6750.2 |
Total Current Liabilities | 11714.2 | 15093.2 | 13682 | 15052.7 | 13386 |
Accounts Payable | 1639.6 | 1597.8 | 1566.8 | 1670.6 | 1433.3 |
Accrued Expenses | 649.9 | 755.5 | 836.6 | 958.1 | 693.1 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 4.9 | 1778.5 | 1563 | 1538.3 | 1355.9 |
Other Current Liabilities, Total | 9419.8 | 10961.4 | 9715.6 | 10885.7 | 9903.7 |
Total Liabilities | 39939.6 | 41364.6 | 40430 | 39826.8 | 37588.5 |
Total Long Term Debt | 16199.6 | 14736.6 | 15522.4 | 15346.4 | 15152.9 |
Long Term Debt | 16199.6 | 14736.6 | 15522.4 | 15346.4 | 15152.9 |
Deferred Income Tax | 2200.6 | 1857.3 | 1632.5 | 1733.7 | 1286.1 |
Minority Interest | 200.6 | 219.1 | 197.1 | 175.6 | 131.2 |
Other Liabilities, Total | 9624.6 | 9458.4 | 9396 | 7518.4 | 7632.3 |
Total Equity | 6898.7 | 6444.4 | 7757 | 8979.2 | 9330.8 |
Common Stock | 599.7 | 598.1 | 598.2 | 596.3 | 594.1 |
Additional Paid-In Capital | 6579.2 | 6669.2 | 6758 | 6833.4 | 6656.3 |
Retained Earnings (Accumulated Deficit) | 9181.3 | 8530.1 | 9639.4 | 8958.5 | 9369.4 |
Treasury Stock - Common | -52.7 | -52.7 | -52.7 | -52.7 | -50.5 |
Unrealized Gain (Loss) | 4.5 | 9.1 | 6.8 | 3.7 | -18.1 |
Other Equity, Total | -9413.3 | -9309.4 | -9192.7 | -7360 | -7220.4 |
Total Liabilities & Shareholders’ Equity | 46838.3 | 47809 | 48187 | 48806 | 46919.3 |
Total Common Shares Outstanding | 959.019 | 956.575 | 956.589 | 953.653 | 950.155 |
- Anual
- Trimestrial
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
---|---|---|---|---|---|---|
Venit net/linie de pornire | 2737.6 | -204.1 | 3232 | 8318.4 | 6193.7 | 5581.7 |
Numerar din activități de exploatare | 4851 | 5615.6 | 5524.5 | 4836.6 | 6499.6 | 7260.7 |
Numerar din activități de exploatare | 1496.6 | 1567.3 | 1609 | 1232.6 | 1323.9 | 1547.6 |
Deferred Taxes | 439.5 | -787.9 | 326.8 | 62.4 | -134.5 | -802.3 |
Elemente fără numerar | 661.4 | 1835.4 | 2735.4 | -3089.6 | -136.1 | 1956.3 |
Cash Taxes Paid | 700.6 | 246.5 | 1101.5 | 1180.5 | 954.6 | 1598.8 |
Dobândă plătită la numerar | 146.4 | 192.7 | 223.8 | 305.5 | 345.8 | 338 |
Modificări ale capitalului de lucru | -484.1 | 3204.9 | -2378.7 | -1687.2 | -747.4 | -1022.6 |
Numerar din activități de investiții | -3139.1 | -3783.6 | 1906 | -8082.9 | -2258.9 | -2762.3 |
Cheltuieli de capital | -1092 | -2163.6 | -3018.2 | -1353.5 | -2029.1 | -1873.2 |
Alte elemente ale fluxurilor de numerar pentru investiții, total | -2047.1 | -1620 | 4924.2 | -6729.4 | -229.8 | -889.1 |
Numerar din activități de finanțare | -559.8 | 142.6 | -5904.9 | -2324.5 | -3137.1 | -4131.3 |
Elemente de finanțare a fluxurilor de numerar | -300.8 | -364.4 | -372.8 | -200.1 | -241.6 | -295.9 |
Total Cash Dividends Paid | -2158.5 | -2192.1 | -2311.8 | -2409.8 | -2687.1 | -3086.8 |
Emisiune (retragere) de acțiuni, netă | -600.1 | -299.8 | -2491 | -4400 | -500 | -1250 |
Emiterea (rambursarea) de datorii, netă | 2499.6 | 2998.9 | -729.3 | 4685.4 | 291.6 | 501.4 |
Efectele schimburilor valutare | -236.4 | -20.5 | -63.6 | -89.9 | 216 | -205.7 |
Variația netă a numerarului | 915.7 | 1954.1 | 1462 | -5660.7 | 1319.6 | 161.4 |
Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | |
---|---|---|---|---|---|
Net income/Starting Line | 1355.3 | 2745.5 | 3855.6 | 5581.7 | 1902.9 |
Cash From Operating Activities | 1697.4 | 3472.9 | 5104.2 | 7260.7 | 2499.2 |
Cash From Operating Activities | 350.3 | 719.6 | 1101.9 | 1547.6 | 435.7 |
Deferred Taxes | -119.1 | -413.8 | -709.8 | -802.3 | -506.6 |
Non-Cash Items | 213.7 | 303.2 | 1404.6 | 1956.3 | 712.7 |
Changes in Working Capital | -102.8 | 118.4 | -548.1 | -1022.6 | -45.5 |
Cash From Investing Activities | -1283.5 | -1766.8 | -2383.3 | -2762.3 | -1013.8 |
Capital Expenditures | -492.1 | -1023.4 | -1479 | -1873.2 | -857.2 |
Other Investing Cash Flow Items, Total | -791.4 | -743.4 | -904.3 | -889.1 | -156.6 |
Cash From Financing Activities | -1058.4 | -2141.6 | -2604.8 | -4131.3 | -2878.3 |
Financing Cash Flow Items | -279.9 | -294.8 | -295.3 | -295.9 | -282.4 |
Total Cash Dividends Paid | -774.8 | -1543.1 | -2313.5 | -3086.8 | -885.5 |
Issuance (Retirement) of Stock, Net | 0 | -500 | -500 | -1250 | -1500 |
Issuance (Retirement) of Debt, Net | -3.7 | 196.3 | 504 | 501.4 | -210.4 |
Foreign Exchange Effects | -10.2 | -1.6 | 15 | -205.7 | 33.6 |
Net Change in Cash | -654.7 | -437.1 | 131.1 | 161.4 | -1359.3 |
Nume investitor | Tip de investitor | Procent în circulație | Acțiuni deținute | Variația acțiunilor | Data deținerii | Indicele cifrei de afaceri |
---|---|---|---|---|---|---|
Lilly Endowment, Inc. | Investment Advisor | 10.8347 | 102948810 | -210000 | 2022-12-31 | LOW |
The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 7.6008 | 72221213 | 994066 | 2022-09-30 | LOW |
PNC Wealth Management | Investment Advisor | 5.4451 | 51738161 | -44061 | 2022-09-30 | LOW |
BlackRock Institutional Trust Company, N.A. | Investment Advisor | 4.2364 | 40253792 | 58949 | 2022-09-30 | LOW |
State Street Global Advisors (US) | Investment Advisor/Hedge Fund | 3.5343 | 33582472 | 168444 | 2022-09-30 | LOW |
Fidelity Management & Research Company LLC | Investment Advisor | 3.3604 | 31929656 | 631015 | 2022-09-30 | LOW |
Capital World Investors | Investment Advisor | 3.0547 | 29024874 | 282228 | 2022-09-30 | LOW |
PRIMECAP Management Company | Investment Advisor | 2.9486 | 28017155 | -421333 | 2022-09-30 | LOW |
T. Rowe Price Associates, Inc. | Investment Advisor | 2.5054 | 23805927 | 3379269 | 2022-09-30 | LOW |
Wellington Management Company, LLP | Investment Advisor/Hedge Fund | 2.2989 | 21843288 | -1593968 | 2022-09-30 | LOW |
State Farm Insurance Companies | Insurance Company | 1.8324 | 17410725 | 0 | 2022-09-30 | LOW |
Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 1.6935 | 16091249 | 373938 | 2022-09-30 | LOW |
Jennison Associates LLC | Investment Advisor/Hedge Fund | 1.0592 | 10064742 | -293324 | 2022-09-30 | LOW |
JP Morgan Asset Management | Investment Advisor | 0.866 | 8228610 | 173535 | 2022-09-30 | LOW |
Norges Bank Investment Management (NBIM) | Sovereign Wealth Fund | 0.8435 | 8014500 | -246196 | 2021-12-31 | LOW |
Northern Trust Investments, Inc. | Investment Advisor/Hedge Fund | 0.7439 | 7068030 | -132558 | 2022-09-30 | LOW |
Legal & General Investment Management Ltd. | Investment Advisor/Hedge Fund | 0.6244 | 5933104 | -307204 | 2022-09-30 | LOW |
Capital International Investors | Investment Advisor | 0.5893 | 5599174 | 637189 | 2022-09-30 | LOW |
BlackRock Investment Management (UK) Ltd. | Investment Advisor/Hedge Fund | 0.5885 | 5591703 | -216451 | 2022-09-30 | LOW |
BofA Global Research (US) | Research Firm | 0.5868 | 5576096 | -144521 | 2022-09-30 | LOW |
Why choose Capital.com? Our numbers speak for themselves.
Capital.com GroupTraderi
Clienți activi lunar
Volumul lunar de investiții
Retras în fiecare lună
Calculator de tranzacționare
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
Eli Lilly Company profile
Despre Eli Lilly & Co
Eli Lilly and Company este o companie producătoare de medicamente. Compania este implicată în descoperirea, dezvoltarea, fabricarea, comercializarea și vânzarea de produse farmaceutice în întreaga lume. Printre produsele pentru diabet ale companiei se numără Baqsimi, Basaglar, Humalog, Humulin, Jardiance, Lyumjev, Trajenta și Trulicity. Printre produsele sale oncologice se numără Alimta, Cyramza, Erbitux, Retevmo, Tyvyt și Verzenio. Produsele de imunologie ale companiei constau în Olumiant și Taltz. Produsele sale de neuroștiință includ Cymbalta, Emgality, Reyvow și Zyprexa. Celelalte terapii ale sale constau în Bamlanivimab, etesevimab, Cialis și Forteo. Compania își produce și distribuie produsele prin intermediul unor unități din Statele Unite, inclusiv Puerto Rico, și din alte aproximativ opt țări. Produsele sale sunt vândute în aproximativ 120 de țări. Printre filialele sale se numără, printre altele, Acanthas Pharma, Inc., Alnara Pharmaceuticals, Inc., ARMO Biosciences, Inc. și Avid Radiopharmaceuticals, Inc.
Industry: | Pharmaceuticals (NEC) |
Lilly Corporate Ctr
Drop Code 1094
INDIANAPOLIS
INDIANA 46285-0001
US
Declarația de venituri
- Annual
- Quarterly
Utilizatorii urmăresc și
Încă mai căutați un broker de încredere?
Alăturați-vă celor peste 485.000 de traderi din întreaga lume care au ales să tranzacționeze cu Capital.com